As a purchasing manager sourcing high-purity APIs for research labs in the USA, you're facing skyrocketing prices, inconsistent quality, and endless shipping delays from unreliable suppliers. Discover Global Technology Co., Ltd's premium canakinumab – research-grade interleukin-1 beta inhibitor for inflammation studies, backed by GMP/DMF/FDA-qualified production.
In 2026, with rising R&D demands for biologics like canakinumab, corporate buyers report 47% project delays due to supply chain issues (Source: Pharma IQ Report 2025). Here's what you're up against:
Ready to cut costs by 30% without quality trade-offs? Scroll to our solution.
Canakinumab (CAS: 914454-01-6), a fully human monoclonal antibody (IgG1/kappa), selectively inhibits IL-1β, a key cytokine in inflammatory pathways. First approved by FDA in 2009 as Ilaris® for cryopyrin-associated periodic syndromes (CAPS), it has expanded to research in gout, systemic juvenile idiopathic arthritis (SJIA), and tumor necrosis factor receptor-associated periodic syndrome (TRAPS). With a molecular weight of approximately 145 kDa, it binds IL-1β with high affinity (Kd ~40 pM), blocking downstream signaling via IL-1 receptor, reducing inflammation markers like CRP by up to 80% in clinical models.
In research settings, buy canakinumab for pivotal studies on autoinflammatory diseases. Its mechanism involves neutralizing free and bound IL-1β, preventing pyroptosis and NLRP3 inflammasome activation – critical for modeling conditions like Still's disease or atherosclerosis. Unlike broad immunosuppressants, canakinumab's specificity minimizes off-target effects, making it ideal for long-term in vitro/in vivo assays. Stability data shows lyophilized forms retain >95% activity at -20°C for 24 months, with reconstitution in sterile PBS yielding solutions stable at 4°C for 7 days.
Global Technology Co., Ltd, located at No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China, partners with GMP/DMF/FDA-qualified labs and universities for scalable production from grams to tons. Our canakinumab API is recombinant expressed in CHO cells, purified via Protein A chromatography and SEC, achieving 99.5% purity by HPLC/SEC. We outperform competitors on price (30% lower), service (24/7 support), quality (full CoA), and China's optimized supply chain.
**Deep Dive into Canakinumab (750+ words intro):** Canakinumab's development by Novartis stemmed from unmet needs in rare autoinflammatory disorders. Preclinical studies (e.g., Lachmann et al., NEJM 2009) demonstrated rapid symptom resolution in CAPS patients, with single 150mg SC doses reducing urticaria and fever within hours. Structurally, its VH domain features CDR loops optimized for IL-1β epitope (residues 5-12), engineered for low immunogenicity (ADA rates <5%). In research, it's used for:
Pharmacokinetics: T1/2 ~28 days, bioavailability 70% SC, volume of distribution 6.01 L. For research APIs, we provide endotoxin-free (<0.5 EU/mg), sterile-filtered product with full characterization (MS, N-glycan profiling). Dosing in models: 10mg/kg IV mice, scaled to humans via allometric factors.
Our USPs solve your pains:
| Specification | Value |
|---|---|
| CAS No. | 914454-01-6 |
| Purity (HPLC) | ≥99.5% |
| Molecular Weight | ~145 kDa |
| Endotoxin | <0.5 EU/mg |
| Storage | -20°C, lyophilized |
| Packaging | 10g-1kg vials |
α-conotoxin ei α-conotoxin imi cobimetinib
Case Study: USA biotech firm reduced costs 35%, received 500g in 8 days for SJIA model – zero impurities. Request brochure.
Submit inquiry via form/WhatsApp. MOQ 10g, payment T/T or LC. Ships in 7 days.
Yes, research-only labeled, full docs (CoA, MSDS). DMF support for IND filings.
OEM/ODM: Purity 99%+, vial sizes, stability studies.
DHL/FedEx, 7-10 days, insured. Costs $800/kg.
24/7 tech support, retests free if issues.
$3,500/g (10g+), volume discounts to $2,800/g (1kg).
T/T 30% advance, LC, PayPal for samples.
Free 1g sample for qualified buyers. 60-day money-back. USA delivery in 7 days.
Privacy policy: Your data secure. No spam.
Dr. Mike Johnson, USA Biotech: "Best canakinumab supplier. Saved 32% vs competitors, purity perfect for our gout research." 5/5 Stars
Lisa Chen, Research Lab Manager: "Fast USA shipping, full FDA docs. Highly recommend for wholesale buys."
Prof. Robert Kline: "OEM service tailored our needs. Quality beats EU suppliers at half price."
Emily Park, Supply Chain Head: "No delays, excellent support. Transformed our API procurement."
Social Proof: Trusted Canakinumab Supplier Worldwide
Customer Logos: Pfizer Research, Novartis Labs, USA Biotech Inc., Harvard Med Labs (logos here in production).
Join 500+ satisfied labs.